Journal List > Korean J Gastroenterol > v.64(5) > 1007302

Oh, Kim, Cha, Kim, Kim, Jung, Lee, and Lee: A Case of Malignant Perivascular Epithelioid Cell Tumor of the Retroperitoneum with Multiple Metastases

Abstract

Perivascular epithelioid cell tumors (PEComas) are unusual mesenchymal neoplasms composed of histologically and immunohistochemically distinct perivascular epithelioid cells (PECs). Although PEComas have the potential to behave in a malignant fashion, malignant PEComas arising from the retroperitoneum are extremely rare. A 68-year-old woman presented with a painful palpable mass in her left upper abdomen. Computed tomography of the abdomen showed a 9 cm sized heterogeneous mass in left para-aortic space and multiple hypervascular nodules in the liver. 18 F-fludeoxyglucose-PET/CT showed multifocal hyper-metabolic lesions in retroperitoneum, liver, and skeletal bones. Percutaneous needle biopsies were done on the retroperitoneal and hepatic mass. Both specimens were positive for human melanoma black-45 (HMB-45) on histological and immunohistochemical staining which was compatible with PEComas. Herein, we report a rare case of retroperitoneal PEComa with multiple metastases involving liver and bone at initial diagnosis that exhibited aggressive behavior and resulted in a devastating prognosis.

References

1. Bonetti F, Pea M, Martignoni G, Zamboni G. PEC and sugar. Am J Surg Pathol. 1992; 16:307–308.
crossref
2. Pea M, Martignoni G, Zamboni G, Bonetti F. Perivascular epithelioid cell. Am J Surg Pathol. 1996; 20:1149–1153.
crossref
3. Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol. 2010; 41:1–15.
crossref
4. Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW. Perivascular epithelioid cell neoplasms of soft tissue and gyne-cologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005; 29:1558–1575.
5. Hornick JL, Fletcher CD. Sclerosing PEComa: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum. Am J Surg Pathol. 2008; 32:493–501.
crossref
6. Ruco LP, Pilozzi E, Wedard BM, et al. Epithelioid lymphangioleio-myomatosis-like tumour of the uterus in a patient without tuber-ous sclerosis: a lesion mimicking epithelioid leiomyosarcoma. Histopathology. 1998; 33:91–93.
crossref
7. Hornick JL, Fletcher CD. PEComa: what do we know so far? Histopathology. 2006; 48:75–82.
crossref
8. Yokoo H, Isoda K, Nakazato Y, et al. Retroperitoneal epithelioid angiomyolipoma leading to fatal outcome. Pathol Int. 2000; 50:649–654.
crossref
9. Lau SK, Marchevsky AM, McKenna RJ Jr, Luthringer DJ. Malignant monotypic epithelioid angiomyolipoma of the retroperitoneum. Int J Surg Pathol. 2003; 11:223–228.
crossref
10. Gupta C, Malani AK, Gupta V, Singh J, Ammar H. Metastatic retroperitoneal epithelioid angiomyolipoma. J Clin Pathol. 2007; 60:428–431.
crossref
11. Lans TE, van Ramshorst GH, Hermans JJ, den Bakker MA, Tran TC, Kazemier G. Perivascular epithelioid cell tumor of the retroperitoneum in a young woman resulting in an abdominal chyloma. J Gastrointest Surg. 2009; 13:389–392.
crossref
12. Subbiah V, Trent JC, Kurzrock R. Resistance to mammalian tar-get of rapamycin inhibitor therapy in perivascular epithelioid cell tumors. J Clin Oncol. 2010; 28:e415.
crossref
13. de León DC, Pérez-Montiel D, Bandera A, Villegas C, Gonzalez- Conde E, Vilchis JC. Perivascular epithelioid cell tumor of abdominal origin. Ann Diagn Pathol. 2010; 14:173–177.
crossref
14. Wagner AJ, Malinowska-Kolodziej I, Morgan JA, et al. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol. 2010; 28:835–840.
crossref
15. Wu JH, Zhou JL, Cui Y, Jing QP, Shang L, Zhang JZ. Malignant perivascular epithelioid cell tumor of the retroperitoneum. Int J Clin Exp Pathol. 2013; 6:2251–2256.
16. Scheppach W, Reissmann N, Sprinz T, Schippers E, Schoettker B, Mueller JG. PEComa of the colon resistant to sirolimus but responsive to doxorubicin/ifosfamide. World J Gastroenterol. 2013; 19:1657–1660.
crossref
17. Koenig AM, Quaas A, Ries T, et al. Perivascular epitheloid cell tumour (PEComa) of the retroperitoneum - a rare tumor with uncertain malignant behaviour: a case report. J Med Case Rep. 2009; 3:62.
crossref
18. Gennatas C, Michalaki V, Kairi PV, Kondi-Paphiti A, Voros D. Successful treatment with the mTOR inhibitor everolimus in a patient with perivascular epithelioid cell tumor. World J Surg Oncol. 2012; 10:181.
crossref

Fig. 1.
Abdominal enhanced computer tomography shows multiple hypervascular nodules in the liver (A) and 9 cm sized heterogenous enhancing mass in left para-aortic space (B).
kjg-64-302f1.tif
Fig. 2.
PET/CT scan shows 18 F-fludeoxyglucose hot uptakes in the liver (A) and left para-aortic space mass (B).
kjg-64-302f2.tif
Fig. 3.
(A) The tumor shows nested epithelioid tumor cells with round nucleus and granular eosinophilic or clear cytoplasm (H&E, ×200). The tumor cells are positive for HMB-45 (B, ×200), but negative for smooth muscle actin (C, ×200) and S-100 (D, ×200).
kjg-64-302f3.tif
Table 1.
Proposed Classification of Perivascular Epithelioid Cell Tumors by Folpe et al.3,4
Risk features Risk category
Size >5 cm Benign; <2 high risk features and size <5 cm
Infiltrative growth pattern Uncertain malignant potential; size >5 cm with no other high risk features
High nuclear grade and cellularity or nuclear pleomorphism/multinucleated giant cells only
Mitotic rate >1/50 HPF Malignant; 2 or more high risk features
Necrosis  
Vascular invasion  
Table 2.
Summary of Previously Reported Cases of Malignant Retroperitoneal Perivascular Epithelioid Cell Tumors
Author (year) Age (yr)/sex Presenting symptoms Size (cm) Location of tumor Metastasis at initial diagnosis Treatment Outcome
Yokoo et al. (2000)8 38/F Lumbar pain 30 Near the left kidney Regional lymph node Surgery, CTx, RT Peritoneum metastasis after 1 year; dead after 4 years
Lau et al. (2003)9 29/M Dyspepsia 20 Near the splenic flexure None Surgery Liver metastases after 9 years; thymus and lung metastases after 17 years
Gupta et al. (2007)10 80/F Abdominal pain 15 Abutting left kidney Liver Surgery Bone metastasis after 1 year
Lans et al. (2009)11 28/F LLQ pain 15 Posterior to the left broad ligament None Surgery NED at 1 year
Subbiah et al. (2010)12 58/F RUQ mass 17 Above the right kidney None Surgery, adjuvant CTx Liver metastasis after 2 years
de León et al. (2010)13 38/F Abdominal pain 7 Near the renal hilum None Surgery Dead after 18 months
Wagner et al. (2010)14 65/M Not available 20 Not available Peritoneal seeding Surgery Recur after 3 months
Wu et al. (2013)15 55/F RLQ discomfort 7.5 Front of the right psoas muscle None Surgery Liver metastasis after 7 months

CTx, chemotherapy; RT, radiation therapy; LLQ, left lower quadrant; RUQ, right upper quadrant; RLQ, right lower quadrant; NED, no evidence of disease.

TOOLS
Similar articles